The P2X7 receptor as a therapeutic target

Expert Opinion on Therapeutic Targets
Romeo RomagnoliStefania Gessi

Abstract

The P2X7 receptor is present in a variety of cell types involved in pain, inflammatory processes and neurodegenerative conditions, thus it may be an appealing target for pharmacological intervention. The extensive use of high-throughput screening (HTS) followed by a hit-to-lead (HtL) program, has prompted a number of firms to identify highly selective and metabolically stable small-molecules possessing activity for both the rat and human P2X(7) receptor, which provide a novel therapeutic approach to the treatment of pain as well as neurodegenerative and inflammatory disorders. To describe the current status of and potential for development of P2X(7) receptor-antagonists. A literature review. We describe the recent discoveries of novel P2X(7) receptor-selective antagonists, along with their biological activity and therapeutic potential.

References

Mar 1, 1995·The Journal of Clinical Investigation·S FalzoniF Di Virgilio
Jan 5, 1996·Biochemical and Biophysical Research Communications·P ChiozziF Di Virgilio
Feb 28, 1997·The Journal of Biological Chemistry·F RassendrenA Surprenant
Apr 1, 1997·British Journal of Pharmacology·C E Gargett, J S Wiley
Nov 19, 1997·Neuropharmacology·G ColloG Buell
Nov 19, 1997·Neuropharmacology·D FerrariF Di Virgilio
Aug 28, 1998·British Journal of Pharmacology·I P ChessellP P Humphrey
May 18, 1999·The American Journal of Physiology·R Coutinho-SilvaD M Ojcius
Nov 24, 1999·The Journal of Biological Chemistry·O R BaricordiF Di Virgilio
Apr 13, 2000·Bioorganic & Medicinal Chemistry Letters·P G BaraldiF di Virgilio
Apr 26, 2000·British Journal of Pharmacology·A D HibellA D Michel
Oct 4, 2000·The Journal of Biological Chemistry·M SolleC A Gabel
Mar 23, 2001·Trends in Pharmacological Sciences·F Di VirgilioP Illes
Aug 2, 2002·European Journal of Pharmacology·Rosalind Le FeuvreNancy Rothwell
Sep 25, 2002·Physiological Reviews·R Alan North
Nov 1, 2003·Bioorganic & Medicinal Chemistry Letters·L AlcarazM Robertson
Nov 1, 2003·Bioorganic & Medicinal Chemistry Letters·Andrew BaxterPeter Webborn
May 19, 2004·Clinical and Experimental Immunology·J A Gracie
Aug 5, 2004·Journal of Neuropathology and Experimental Neurology·Heike FrankePeter Illes
Oct 8, 2004·American Journal of Physiology. Cell Physiology·R X FariaLuiz Anastácio Alves
Dec 18, 2004·Bioorganic & Medicinal Chemistry Letters·Gregory H MerrimanDouglas Macdonald
Jun 24, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Giulio CabriniFrancesco Di Virgilio
Jul 19, 2005·Nature Cell Biology·James I ElliottChristopher F Higgins
Aug 12, 2005·American Journal of Physiology. Cell Physiology·Lin-Hua JiangR Alan North
Mar 21, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Davide FerrariFrancesco Di Virgilio
Mar 28, 2006·Trends in Neurosciences·Christopher M Anderson, Maiken Nedergaard
May 5, 2006·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Nicholas BardenBertram Müller-Myhsok
May 16, 2006·Progress in Neurobiology·Beáta SperlághPeter Illes
Jul 14, 2006·Journal of Neurochemistry·Fabio BiancoClaudia Verderio
Oct 13, 2006·British Journal of Pharmacology·L StokesA Surprenant
Oct 13, 2006·Molecular Pharmacology·Mark T YoungAnnmarie Surprenant
Nov 11, 2006·American Journal of Respiratory and Critical Care Medicine·Suran L FernandoWarwick J Britton
Nov 24, 2006·The Journal of Biological Chemistry·Pablo Pelegrin, Annmarie Surprenant

❮ Previous
Next ❯

Citations

Apr 13, 2011·Purinergic Signalling·Helio Miranda Costa-JuniorRobson Coutinho-Silva
Nov 6, 2012·Journal of Medicinal Chemistry·Sharan K BagalNigel A Swain
Apr 10, 2010·The Journal of Biological Chemistry·Sébastien RogerPablo Pelegrin
Sep 13, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Liam E Browne, R Alan North
Feb 28, 2014·TheScientificWorldJournal·Torben Madsen KvistNiklas Rye Jørgensen
Oct 29, 2013·Purinergic Signalling·Wolfgang FischerMichael Schaefer
Mar 9, 2010·Expert Opinion on Therapeutic Patents·Hendra Gunosewoyo, Michael Kassiou
Oct 23, 2009·Expert Opinion on Therapeutic Targets·George I Gorodeski
Sep 18, 2012·Gastroenterology·Paul Kubes, Wajahat Z Mehal
May 4, 2011·Bioorganic & Medicinal Chemistry Letters·Arturo Perez-MedranoWilliam A Carroll
Feb 16, 2011·Toxicology and Applied Pharmacology·Ga Eun LeeYong-Chul Kim
Oct 12, 2010·Bioorganic & Medicinal Chemistry Letters·Lee AbberleyDaryl S Walter
Jul 17, 2010·Bioorganic & Medicinal Chemistry Letters·Robert J GleaveSac-Pham Tang
Apr 20, 2010·Bioorganic & Medicinal Chemistry Letters·Laura J ChambersStefan Senger
Jun 23, 2009·Bioorganic & Medicinal Chemistry·Hendra GunosewoyoMichael Kassiou
Mar 14, 2009·European Journal of Immunology·Leanne Stokes, Annmarie Surprenant
Apr 5, 2011·British Journal of Pharmacology·Helen J BradleyLin-Hua Jiang
Jul 24, 2013·Journal of Gastroenterology and Hepatology·Rafaz HoqueWajahat Z Mehal
Aug 30, 2011·Biochimica Et Biophysica Acta·Christoph KubickFritz Markwardt
Feb 9, 2010·Biochimica Et Biophysica Acta·B FlittigerF Markwardt
Jul 26, 2011·Bioorganic & Medicinal Chemistry Letters·Chakrapani SubramanyamMichael Fisher
Mar 17, 2010·Trends in Pharmacological Sciences·Liam E BrowneR Alan North
Jul 29, 2008·Neuropharmacology·Michael F Jarvis, Baljit S Khakh
Mar 26, 2013·European Journal of Pharmacology·Geoffrey Burnstock
Jul 19, 2016·Bioorganic & Medicinal Chemistry Letters·Jason C RechBrad M Savall
Jul 6, 2016·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·R Alan North
Apr 11, 2013·ACS Medicinal Chemistry Letters·Michael A LetavicAnindya Bhattacharya
Jun 10, 2016·PloS One·Wolfgang FischerTobias Engel
Oct 6, 2009·Bioorganic & Medicinal Chemistry Letters·Ju-Yeon LeeYong-Chul Kim
Jun 15, 2014·Pharmacological Reviews·Rachael BartlettRonald Sluyter
May 12, 2009·Acta Biochimica Et Biophysica Sinica·Xiujun ZhangDong An
Oct 22, 2010·American Journal of Physiology. Renal Physiology·Abolfazl Zarjou, Anupam Agarwal

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved